Mobile version of Hanspub

文章引用说明 更多>> (返回到该文章)

张琳, 陈金梅. 口服茵栀黄和妈咪爱治疗新生儿黄疸88例[J]. 临床医学, 2011, 31(3): 119.

被以下文章引用:

  • 标题: 妈咪爱治疗新生儿黄疸的临床疗效分析Clinical Efficiency of Medilac-Vita in Children with Neonatal Jaundice

    作者: 张立明, 门光国, 马晓媚

    关键字: 新生儿黄疸, 胆红素, 妈咪爱, 治疗Neonatal Jaundice; Bilirubin Medilac-Vita; Treatment

    期刊名称: 《Asian Case Reports in Pediatrics》, Vol.1 No.3, 2013-08-02

    摘要: 目的:观察分析妈咪爱在新生儿黄疸治疗中的临床疗效。方法:112例新生儿黄疸患儿随机分为治疗组和对照组,每组56例。两组都给予常规治疗,治疗组在常规治疗基础上加服妈咪爱,并通过动态检测经皮测胆红素观察其临床疗效。结果:治疗组患儿血清胆红素与对照组比较下降明显(P 0.01),且治疗组治疗7天后的有效率及治愈率方面明显优于对照组。结论:妈咪爱治疗新生儿黄疸,可迅速降低血清胆红素的水平,优于常规治疗。 Objective: To observe the clinical efficiency of Medilac-Vita in children with neonatal jaundice. Methods: 112 cases of newborn with neonatal jaundice were randomly divided into treatment group and control group. All were treated with routine therapy. Oral Medilac-Vita was added to the treatment group. Clinical efficiency was observed by detection of transcautaneous bilirubin. Results: The level of transcautaneous bilirubin in treatment group was significantly lower than the control group. After 7 days of treatment, the effective rate and cure rate of the treatment group are obviously better than the control group. Conclusions: Moreover, the effect of Medilac-Vita in treatment of neonatal jaundice is better than routine treatment, it can reduce the serum bilirubin rapidly.